The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents

Direct-acting antiviral agents (DAAs) have been widely used for chronic hepatitis C (CHC) treatment recently. The characteristics of glucose abnormalities after DAAs therapy however, remain elusive. We aimed to elucidate the mutual impact between treatment response and parameters of glucose abnormal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Meng-Hsuan Hsieh, Jeng-Fu Yang, Ching-I. Huang, Yi-Hung Lin, Po-Cheng Liang, Zu-Yau Lin, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long Chuang
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2017-11-01
Col·lecció:	Kaohsiung Journal of Medical Sciences
Matèries:	Hepatitis C virus Direct antiviral agents Insulin resistance
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1607551X17302760
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!